Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0234 Transporter Info
Gene Name	SLC26A6
Transporter Name	Anion exchange transporter
Gene ID	65010
UniProt ID	Q9BXS9

Post-Translational Modification of This DT
Overview of SLC26A6 Modification Sites with Functional and Structural Information
Sequence	M G L A D A S G P R D T Q A L L S A T Q A M D L R R R D Y H M E R P L L N Q E H L E E L G R W G S A P R T H Q W R T W L Q C S R A R A Y A L L L Q H L P V L V W L P R Y P V R D W L L G D L L S G L S V A I M Q L P Q G L A Y A L L A G L P P V F G L Y S S F Y P V F I Y F L F G T S R H I S V G T F A V M S V M V G S V T E S L A P Q A L N D S M I N E T A R D A A R V Q V A S T L S V L V G L F Q V G L G L I H F G F V V T Y L S E P L V R G Y T T A A A V Q V F V S Q L K Y V F G L H L S S H S G P L S L I Y T V L E V C W K L P Q S K V G T V V T A A V A G V V L V V V K L L N D K L Q Q Q L P M P I P G E L L T L I G A T G I S Y G M G L K H R F E V D V V G N I P A G L V P P V A P N T Q L F S K L V G S A F T I A V V G F A I A I S L G K I F A L R H G Y R V D S N Q E L V A L G L S N L I G G I F Q C F P V S C S M S R S L V Q E S T G G N S Q V A G A I S S L F I L L I I V K L G E L F H D L P K A V L A A I I I V N L K G M L R Q L S D M R S L W K A N R A D L L I W L V T F T A T I L L N L D L G L V V A V I F S L L L V V V R T Q M P H Y S V L G Q V P D T D I Y R D V A E Y S E A K E V R G V K V F R S S A T V Y F A N A E F Y S D A L K Q R C G V D V D F L I S Q K K K L L K K Q E Q L K L K Q L Q K E E K L R K Q A A S P K G A S V S I N V N T S L E D M R S N N V E D C K M M Q V S S G D K M E D A T A N G Q E D S K A P D G S T L K A L G L P Q P D F H S L I L D L G A L S F V D T V C L K S L K N I F H D F R E I E V E V Y M A A C H S P V V S Q L E A G H F F D A S I T K K H L F A S V H D A V T F A L Q H P R P V P D S P V S V T R L
PTM type	X-Phosphorylation X-S-nitrosylation X-S-palmitoylation X-Ubiquitination X: Amino Acid

Phosphorylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Affecting the surface membrane expression of SLC26A6			[1]
Role of PTM	Surface Expression Modulation
Modified Residue	Asparagine	Modified Location	167
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Material(s)	Human embryonic kidney (HEK) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Asparagine 167 have been reported to affect its surface membrane expression.
PTM Phenomenon 2	Affecting the surface membrane expression of SLC26A6			[1]
Role of PTM	Surface Expression Modulation
Modified Residue	Asparagine	Modified Location	172
Related Enzyme	Protein kinase C alpha type (PRKCA)
Experimental Material(s)	Human embryonic kidney (HEK) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Asparagine 172 have been reported to affect its surface membrane expression.
Serine	14 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	7
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 7 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC26A6			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	17
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 17 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC26A6			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	342
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 342 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC26A6			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	574
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 574 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC26A6			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	603
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 603 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC26A6			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	608
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 608 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC26A6			[6] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	610
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 610 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC26A6			[5] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	616
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 616 has the potential to affect its expression or activity.
PTM Phenomenon 9	Have the potential to influence SLC26A6			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	634
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 634 has the potential to affect its expression or activity.
PTM Phenomenon 10	Have the potential to influence SLC26A6			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	635
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 635 has the potential to affect its expression or activity.
PTM Phenomenon 11	Have the potential to influence SLC26A6			[9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	650
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 650 has the potential to affect its expression or activity.
PTM Phenomenon 12	Have the potential to influence SLC26A6			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	734
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 734 has the potential to affect its expression or activity.
PTM Phenomenon 13	Have the potential to influence SLC26A6			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	752
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 752 has the potential to affect its expression or activity.
PTM Phenomenon 14	Have the potential to influence SLC26A6			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	755
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Serine 755 has the potential to affect its expression or activity.
Threonine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[2] , [15]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	12
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Threonine 12 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC26A6			[2]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	19
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Threonine 19 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC26A6			[6] , [8]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	615
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Threonine 615 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC26A6			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	643
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Threonine 643 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC26A6			[10]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	740
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Threonine 740 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC26A6			[8] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	757
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC26A6 Threonine 757 has the potential to affect its expression or activity.
S-nitrosylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[16]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	628
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-nitrosylation (-SNO) at SLC26A6 Cystine 628 has the potential to affect its expression or activity.
S-palmitoylation
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[17]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	62
Experimental Method	Co-Immunoprecipitation
Detailed Description	S-palmitoylation at SLC26A6 Cystine 62 has the potential to affect its expression or activity.
Ubiquitination
Lysine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Decreasing cell surface expression of SLC26A6			[18]
Role of PTM	Surface Expression Modulation
Modified Residue	Lysine	Modified Location	535
Studied Phenotype	Hepatoblastoma [ICD11: 2C12.01]
Experimental Material(s)	Human hepatoblastoma (HepG2.2.15) cells
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC26A6 Lysine 535 have been reported to decrease its cell surface expression.
PTM Phenomenon 2	Have the potential to influence SLC26A6			[19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	638
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC26A6 Lysine 638 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC26A6			[19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	651
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC26A6 Lysine 651 has the potential to affect its expression or activity.
Phenylalanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[19]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	499
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC26A6 Phenylalanine 499 has the potential to affect its expression or activity.
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[19]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	650
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC26A6 Serine 650 has the potential to affect its expression or activity.
Threonine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC26A6			[19]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	615
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC26A6 Threonine 615 has the potential to affect its expression or activity.

References
1	N-glycosylation and topology of the human SLC26 family of anion transport membrane proteins. Am J Physiol Cell Physiol. 2014 May 15;306(10):C943-60.
2	An integrated strategy for highly sensitive phosphoproteome analysis from low micrograms of protein samples. Analyst. 2018 Jul 23;143(15):3693-3701.
3	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4	Metabolon disruption: a mechanism that regulates bicarbonate transport. EMBO J. 2005 Jul 20;24(14):2499-511.
5	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
6	Tip-Based Fractionation of Batch-Enriched Phosphopeptides Facilitates Easy and Robust Phosphoproteome Analysis. J Proteome Res. 2018 Jan 5;17(1):46-54.
7	Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants. Elife. 2016 Sep 30;5:e18296.
8	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
9	Identification of missing proteins in the neXtProt database and unregistered phosphopeptides in the PhosphoSitePlus database as part of the Chromosome-centric Human Proteome Project. J Proteome Res. 2013 Jun 7;12(6):2414-21.
10	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
11	Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Mol Cell Proteomics. 2009 Dec;8(12):2796-808.
12	Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat Commun. 2019 Jan 10;10(1):104.
13	The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 Aug 6;182(3):685-712.e19.
14	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
15	A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
16	Proteome-wide detection of S-nitrosylation targets and motifs using bioorthogonal cleavable-linker-based enrichment and switch technique. Nat Commun. 2019 May 16;10(1):2195.
17	Selective Enrichment and Direct Analysis of Protein S-Palmitoylation Sites. J Proteome Res. 2018 May 4;17(5):1907-1922.
18	Global analysis of HBV-mediated host proteome and ubiquitylome change in HepG2.2.15 human hepatoblastoma cell line. Cell Biosci. 2021 Apr 17;11(1):75.
19	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence